|
| |
| | 69166 | | 15.02.2023 | | iQone Healthcare Switzerland SA | | | | | | 14.02.2028 | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| Seq.-No. | Product | Description | Galenic form | ATC-classification | |
---|
01 | Vegzelma 100 mg/4 ml | solution à diluer pour perfusion | Concentrate for infusion (Bevacizumab 100mg / 4ml) | Codice | | 02 | Vegzelma 400 mg/16 ml | solution à diluer pour perfusion | Concentrate for infusion (Bevacizumab 400mg / 16ml) | Codice | |
|
|
|